You may not realize you’ve benefited from HIV research. But if you’ve received a treatment that was approved through a recent ...

Fred Hutch bioengineer Dr. Matthias Stephan is working to develop a special foam that could help make gene therapy for blood ...

GVHD can range from mild and temporary to life-threatening and chronic — but the deadly, debilitating cases are rare now. As ...

Fred Hutch's Value in Cancer Care conference, held November 6, focused on patient and provider burnout; the growing data ...

In this episode of the Oncology Insights Podcast, Dr. Petros Grivas welcomes Dr. Christina Rodriguez to discuss her journey ...

Our research on cell-based therapies also includes cutting-edge immunotherapies that harness the patient’s own immune cells to fight disease, including genetic engineering of immune cells to attack ...

HICOR’s Value in Cancer Care Initiative (VCCI) engages oncology providers, patient partners, payers, health system representatives and researchers to improve the value of cancer care delivery in ...

A new $5.2 million grant from the Washington Research Foundation will help develop a new clinical trials program between Fred Hutch Cancer Center and Seattle Children’s Research Institute.

SEATTLE – October 27, 2025 –Leaders in HIV research highlighted the critical role of that research has played in advancing HIV science over the past 40 years. In a commentary in Nature Medicine, they ...

Affiliate Professor, Herbold Computational Biology Program, Public Health Sciences Division, Fred Hutch Affiliate Professor, Herbold Computational Biology Program Public Health Sciences Division, Fred ...